{"text": ["Dodge", "&", "Cox", "Comments", "on", "Eli", "Lilly"], "created_at": "2018-02-13 22:42:25"}
{"text": ["Dodge", "&", "Cox", "4th", "Quarter", "Commentary"], "created_at": "2018-02-13 22:27:26"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/13/2018:", "ABC,WBA,LLY,BDX,DARE"], "created_at": "2018-02-13 21:26:57"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/13/2018:", "ABC,WBA,LLY,BDX,DARE"], "created_at": "2018-02-13 21:26:57"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/13/2018:", "DARE,LLY,BDX"], "created_at": "2018-02-13 19:26:59"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/13/2018:", "DARE,LLY,BDX"], "created_at": "2018-02-13 19:26:59"}
{"text": ["How", "Pfizer", "Performed", "Overall", "in", "4Q17", "and", "2017"], "created_at": "2018-02-13 19:01:13"}
{"text": ["Pfizer", "Announces", "FDA", "Acceptance", "of", "NDA", "for", "NSCLC", "Candidate"], "created_at": "2018-02-13 18:07:51"}
{"text": ["Pfizer", "Announces", "FDA", "Acceptance", "of", "NDA", "for", "NSCLC", "Candidate"], "created_at": "2018-02-13 18:07:51"}
{"text": ["Better", "Buy:", "Eli", "Lilly", "and", "Company", "vs.", "Johnson", "&", "Johnson"], "created_at": "2018-02-13 15:09:14"}
{"text": ["Better", "Buy:", "Eli", "Lilly", "and", "Company", "vs.", "Johnson", "&", "Johnson"], "created_at": "2018-02-13 15:09:14"}
{"text": ["Eli", "Lilly", "and", "Company", "(LLY)", "Ex-Dividend", "Date", "Scheduled", "for", "February", "14,", "2018"], "created_at": "2018-02-13 14:19:57"}
{"text": ["Eli", "Lilly", "and", "Company", "(LLY)", "Ex-Dividend", "Date", "Scheduled", "for", "February", "14,", "2018"], "created_at": "2018-02-13 14:19:57"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/13/2018:", "JNJ,", "PFE,", "ABT,", "MRK,", "AMGN,", "ABC,", "GNC,", "LLY,", "DARE,", "HCM,", "CLLS,", "BDX"], "created_at": "2018-02-13 14:07:45"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/13/2018:", "JNJ,", "PFE,", "ABT,", "MRK,", "AMGN,", "ABC,", "GNC,", "LLY,", "DARE,", "HCM,", "CLLS,", "BDX"], "created_at": "2018-02-13 14:07:45"}
{"text": ["Better", "Buy:", "Eli", "Lilly", "and", "Company", "vs.", "Johnson", "&", "Johnson"], "created_at": "2018-02-13 13:18:00"}
{"text": ["Eli", "Lilly's", "Taltz", "meets", "primary", "endpoint", "in", "late-state", "trial", "for", "AS", "treatment"], "created_at": "2018-02-13 12:23:42"}
{"text": ["Lilly", "Announces", "Positive", "Top-Line", "Phase", "3", "Results", "for", "Taltz\u00ae", "(ixekizumab)", "in", "Ankylosing", "Spondylitis", "(Radiographic", "Axial", "Spondyloarthritis)"], "created_at": "2018-02-13 11:45:00"}
{"text": ["Eli", "Lilly:", "Taltz", "Phase", "3", "Study", "Meets", "Endpoints", "To", "Treat", "Ankylosing", "Spondylitis"], "created_at": "2018-02-13 07:02:00"}
{"text": ["Eli", "Lilly:", "Taltz", "Phase", "3", "Study", "Meets", "Endpoints", "To", "Treat", "Ankylosing", "Spondylitis"], "created_at": "2018-02-13 07:02:00"}
